Discriminatory accuracy and potential clinical utility of genomic profiling for breast cancer risk in BRCA-negative women

類似資料

• Relative contributions of BRCA1 and BRCA2 mutations to “triple-negative” breast cancer in Ashkenazi Women
  著者:: Comen, E., 等
  出版事項: (2011)
• Improved survival for BRCA2-associated serous ovarian cancer compared to both BRCA-negative and BRCA1-associated serous ovarian cancer
  著者:: Hyman, David M., 等
  出版事項: (2011)
• Incidence of non-founder BRCA1 and BRCA2 mutations in high risk Ashkenazi breast and ovarian cancer families
  著者:: Kauff, N, 等
  出版事項: (2002)
• A Rapid and Reliable Test for BRCA1 and BRCA2 Founder Mutation Analysis in Paraffin Tissue Using Pyrosequencing
  著者:: Zhang, Liying, 等
  出版事項: (2009)
• Germline BRCA mutations denote a clinicopathologic subset of prostate cancer
  著者:: Gallagher, David J., 等
  出版事項: (2010)